Meeting
2019 ASCO Annual Meeting
A phase II study of talazoparib (BMN 673) in patients with homologous recombination repair deficiency (HRRD) positive stage IV squamous cell lung cancer (Lung-MAP Sub-Study, S1400G).
Authors
Taofeek Kunle Owonikoko
Emory University, Atlanta, GA
Taofeek Kunle Owonikoko , Mary Weber Redman , Lauren Averett Byers , Fred R. Hirsch , Philip C. Mack , Lawrence Howard Schwartz , Jeffrey D. Bradley , Tom Stinchcombe , Natasha B. Leighl , Tareq Al Baghdadi , Primo Lara Jr., Jieling Miao , Karen Kelly , Suresh S. Ramalingam , Roy S. Herbst , Vassiliki Papadimitrakopoulou , David R. Gandara
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Clinical Trial Registration Number
NCT02154490
Citation
J Clin Oncol 37, 2019 (suppl; abstr 9022)
DOI
10.1200/JCO.2019.37.15_suppl.9022
Abstract #
9022
Poster Bd #
345
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Prevalence and prognosis of DNA repair deficiency in squamous cell carcinoma (SCC) patients enrolled on the S1400 LungMAP study.
First Author: Taofeek Kunle Owonikoko
Poster
2023 ASCO Annual Meeting
Targeting germline or somatic DNA repair defects (beyond BRCA) in pancreatic cancer with niraparib: A phase II study (NIRA-PANC).
First Author: Anup Kasi
Poster
2023 ASCO Annual Meeting
A four-tier classification system for studying homologous recombination repair gene reversion mutations as a mechanism of resistance to PARP inhibitors and platinum chemotherapy.
First Author: Qiuxiang Ou
Poster
2023 ASCO Annual Meeting
The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?
First Author: Muhammad Danyal Ahsan